Annual Shareholders Equity
$228.54 M
+$34.02 M+17.49%
December 31, 2024
Summary
- As of March 10, 2025, APLS annual stockholders equity is $228.54 million, with the most recent change of +$34.02 million (+17.49%) on December 31, 2024.
- During the last 3 years, APLS annual shareholders equity has risen by +$29.88 million (+15.04%).
- APLS annual shareholders equity is now at all-time high.
Performance
APLS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$228.54 M
-$8.58 M-3.62%
December 31, 2024
Summary
- As of March 10, 2025, APLS quarterly stockholders equity is $228.54 million, with the most recent change of -$8.58 million (-3.62%) on December 31, 2024.
- Over the past year, APLS quarterly shareholders equity has stayed the same.
- APLS quarterly shareholders equity is now -50.56% below its all-time high of $462.24 million, reached on March 31, 2022.
Performance
APLS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
APLS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.5% | 0.0% |
| 3 y3 years | +15.0% | +15.0% |
| 5 y5 years | +567.7% | +15.0% |
APLS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.5% | -50.6% | +34.5% |
| 5 y | 5-year | at high | +567.7% | -50.6% | +261.5% |
| alltime | all time | at high | +4953.4% | -50.6% | +261.5% |
Apellis Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $228.54 M(+17.5%) | $228.54 M(-3.6%) |
| Sep 2024 | - | $237.12 M(-10.3%) |
| Jun 2024 | - | $264.33 M(-0.9%) |
| Mar 2024 | - | $266.68 M(+37.1%) |
| Dec 2023 | $194.52 M(+14.5%) | $194.52 M(-16.3%) |
| Sep 2023 | - | $232.27 M(-32.8%) |
| Jun 2023 | - | $345.40 M(-16.2%) |
| Mar 2023 | - | $412.12 M(+142.6%) |
| Dec 2022 | $169.87 M(-14.5%) | $169.87 M(-44.7%) |
| Sep 2022 | - | $307.42 M(-8.1%) |
| Jun 2022 | - | $334.42 M(-27.7%) |
| Mar 2022 | - | $462.24 M(+132.7%) |
| Dec 2021 | $198.66 M(-2.9%) | $198.66 M(-446.6%) |
| Sep 2021 | - | -$57.33 M(-59.5%) |
| Jun 2021 | - | -$141.49 M(-373.9%) |
| Mar 2021 | - | $51.66 M(-74.7%) |
| Dec 2020 | $204.56 M | $204.56 M(+93.3%) |
| Sep 2020 | - | $105.84 M(-54.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $232.06 M(-10.4%) |
| Mar 2020 | - | $259.00 M(+656.7%) |
| Dec 2019 | $34.23 M(-78.7%) | $34.23 M(-75.5%) |
| Sep 2019 | - | $139.56 M(-12.3%) |
| Jun 2019 | - | $159.09 M(-29.2%) |
| Mar 2019 | - | $224.75 M(+39.6%) |
| Dec 2018 | $160.97 M(+8.1%) | $160.97 M(-17.9%) |
| Sep 2018 | - | $195.95 M(-14.6%) |
| Jun 2018 | - | $229.55 M(+77.9%) |
| Mar 2018 | - | $129.04 M(-13.4%) |
| Dec 2017 | $148.94 M(+526.0%) | $148.94 M(+1120.5%) |
| Sep 2017 | - | $12.20 M(-49.2%) |
| Jun 2017 | - | $24.00 M(+0.9%) |
| Dec 2016 | $23.79 M(-32.0%) | $23.79 M(-32.0%) |
| Dec 2015 | $34.98 M(+164.5%) | $34.98 M(+215.5%) |
| Sep 2015 | - | $11.09 M(-28.7%) |
| Jun 2015 | - | $15.55 M(+17.6%) |
| Dec 2014 | $13.22 M(+192.4%) | $13.22 M |
| Dec 2013 | $4.52 M | - |
FAQ
- What is Apellis Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual shareholders equity year-on-year change?
- What is Apellis Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Apellis Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of APLS is $228.54 M
What is the all time high annual shareholders equity for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual stockholders equity is $228.54 M
What is Apellis Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, APLS annual stockholders equity has changed by +$34.02 M (+17.49%)
What is Apellis Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of APLS is $228.54 M
What is the all time high quarterly shareholders equity for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly stockholders equity is $462.24 M
What is Apellis Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, APLS quarterly stockholders equity has changed by $0.00 (0.00%)